Cigna Corporation has recently released its 10-Q report, providing a comprehensive overview of its financial performance for the first quarter of 2025.
The report showcases Cigna's diverse range of insurance and related products and services offered through its subsidiaries. The Evernorth Health Services segment provides coordinated health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions. The Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers, as well as Medicare and individual health insurance plans.
In the 10-Q, under Item 2 * MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, Cigna highlights its financial measures, including adjusted income from operations, earnings per share, and adjusted revenues. The company emphasizes that these measures are not determined in accordance with GAAP but are used to reflect the underlying results of business operations and facilitate analysis of trends in revenue, expenses, and profitability.
Cigna's consolidated results of operations for the first quarter of 2025, on a GAAP basis, show a 14% increase in total revenues to $65.5 billion, compared to the same period in 2024. The company reported a net income of $1.3 billion, a significant improvement from a net loss of $277 million in the first quarter of 2024. The consolidated effective tax rate also experienced a notable decrease from 368.4% in the first quarter of 2024 to 14.5% in the same period of 2025.
The financial highlights by segment reveal that Evernorth Health Services experienced a 16% increase in adjusted revenues, reaching $53.7 billion in the first quarter of 2025. On the other hand, Cigna Healthcare saw a 9% increase in adjusted revenues, totaling $14.5 billion during the same period.
Furthermore, the company's pre-tax adjusted income from operations for the first quarter of 2025 remained relatively unchanged at $2.3 billion, compared to the same period in 2024. The earnings per share for the quarter also showed a positive trend, with adjusted income from operations per share increasing by 4% to $6.74.
Cigna's 10-Q report provides a detailed and transparent insight into its financial performance, reflecting the company's efforts to maintain a strong and resilient position in the market. Following these announcements, the company's shares moved 0.5%, and are now trading at a price of $336.79. For more information, read the company's full 10-Q submission here.
